Nature Communications (Apr 2021)

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides

  • Éva Kocsmár,
  • György Miklós Buzás,
  • Ildikó Szirtes,
  • Ildikó Kocsmár,
  • Zsófia Kramer,
  • Attila Szijártó,
  • Petra Fadgyas-Freyler,
  • Kató Szénás,
  • Massimo Rugge,
  • Matteo Fassan,
  • András Kiss,
  • Zsuzsa Schaff,
  • Gergely Röst,
  • Gábor Lotz

DOI
https://doi.org/10.1038/s41467-021-22557-7
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Clarithromycin is a macrolide antibiotic widely used for eradication of Helicobacter pylori infection. Here, Kocsmár et al. study clarithromycin resistance and previous macrolide consumption in 4,744 H. pylori-infected patients, shedding light into the sources of primary resistant cases and the role played by prior consumption of macrolides for non-eradication purposes.